✦ LIBER ✦

Cholesterol complacency in Australia: time to revisit the basics of cardiovascular disease prevention

✍ Scribed by Melinda J Carrington; Claudia Retegan; Colin I Johnston; Garry L Jennings; Simon Stewart

Book ID: 108847361
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 210 KB
Volume: 18
Category: Article
ISSN: 0962-1067
DOI: 10.1111/j.1365-2702.2008.02507.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Beyond Cholesterol in the Primary Preven

Beyond Cholesterol in the Primary Prevention of Cardiovascular Disease: Is The Polypill the Answer?

✍ Ginés Sanz 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 141 KB

The role of treatment to increase HDL-ch

The role of treatment to increase HDL-cholesterol and decrease triglyceride concentrations in prevention of coronary heart disease in Type 2 diabetes

✍ S. Wild; C. D. Byrne 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB

Falls prevention in rural general practi

Falls prevention in rural general practice: what stands the test of time and where to from here?

✍ Lisa Barnett; Eric van Beurden; Elizabeth Eakin; Uta Dietrich; John Beard; Beth 📂 Article 📅 2003 🏛 Public Health Association of Australia 🌐 English ⚖ 76 KB

Do the Joint British Society (JBS2) guid

Do the Joint British Society (JBS2) guidelines on prevention of cardiovascular disease with respect to plasma glucose improve risk stratification in the general population? Prospective cohort study

✍ E. J. Brunner; M. J. Shipley; M. G. Marmot; M. Kivimaki; D. R. Witte 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Peroxisome proliferator activated recept

Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men

✍ J. Skogsberg; A. D. McMahon; F. Karpe; A. Hamsten; C. J. Packard; E. Ehrenborg; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Response to Chiasson et al.: Acarbose fo

Response to Chiasson et al.: Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

✍ P. T. Sawicki; T. Kaiser 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 106 KB